Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant.

Abstract

To test the significance of human papillomavirus (HPV) type 16 and HPV16 E6 variants as risk factors for viral persistence and progression to high-grade lesion, we did a nested case-control study within a cohort study of >15,000 Caucasian French women. Three groups infected with high-risk HPV were compared: (a) women with cleared infection (controls, n… (More)

Topics

Cite this paper

@article{Grodzki2006IncreasedRF, title={Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant.}, author={Martha Grodzki and Guillaume Besson and Christine E Clavel and Annie Arslan and Silvia Franceschi and Philippe Birembaut and Massimo Tommasino and Ingeborg Zehbe}, journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology}, year={2006}, volume={15 4}, pages={820-2} }